Xofigo, Bayer Pharma (1 ml of solution contains 1000 kBq of Ra 223 radium dichloride (radium-223 dichloride), corresponding to 0.53 ng radium-223 on the calibration day Radium is present in the free ion solution Rad-223 is the alpha particle emitter and its half-life of radium-223 is 1.9 MBq / ng. The six-step decay of radium-223 to lead-207 occurs through short-lived decay products and is accompanied by alpha, beta and gamma radiation of various energies and The energy emitted from radium-223 and its decay products in the form of alpha particles is 95.3% (energy range 5.0-7.5 MeV) Part of the emission in the form of beta particles is 3.6% (average energy 0.445 MeV and 0.492 MeV) and the part emitted in the form of gamma radiation is 1.1% (energy range 0.01-1,27 MeV) 1 vial contains 6 ml solution (6.0 MBq radium-223 dichloride on day calibration). 1 ml of solution contains 0.194 mmol of sodium (equivalent to 4.5 mg of sodium).)
Zevalin, Bayer Pharma (1 vial contains 3.2 mg of ibritumomab tiuxetan.) The preparation is supplied as a kit for the preparation of yttrium-90 ibritumomab tiuxetan The final formulation after radiolabelling contains 2.08 mg of ibritumomab tiuxetan in a total volume of 10 ml.)